Researchers alter mosquito genome in step toward controlling disease

Mar 21, 2013
Virginia Tech researchers successfully used a gene disruption technique to change the eye color of a mosquito -- a critical step toward new genetic strategies aimed at disrupting the transmission of diseases such as dengue fever. The varied colors of the eyes of these mosquitoes, modified using TALEN technology, is because of cell-to-cell variability in the degree of gene editing. Credit: Virginia Tech

Virginia Tech researchers successfully used a gene disruption technique to change the eye color of a mosquito—a critical step toward new genetic strategies aimed at disrupting the transmission of diseases such as dengue fever.

Zach Adelman and Kevin Myles, both associate professors of entomology in the College of Agriculture and Life Sciences and affiliated researchers with the Fralin Life Science Institute, study the transmission of and develop novel methods of control, based on genetics.

In a groundbreaking study recently published in the journal PLOS ONE, the scientists used a pair of engineered proteins to cut DNA in a site-specific manner to disrupt a targeted gene in the mosquito genome. Science magazine heralded these transcription activator-like effector nuclease proteins, known as TALENS, as a major scientific breakthrough in 2012, nicknaming them "genomic cruise missiles" for their ability to allow researchers to target specific locations with great efficiency.

While TALENS have been previously used to edit the genomes of animal and human cell cultures, applying them to the mosquito genome is a new approach, according to Adelman.

"Unlike model organisms with large collections of to draw upon, the lack of reverse genetic tools in the mosquito has made it is very difficult to assign functions to genes in a definitive manner," Adelman said. "With the development of this technology, our understanding of the genetic basis of many critical behaviors such as blood-feeding, host-seeking and pathogen transmission should be greatly accelerated."

To test the capability of TALENs to specifically edit the mosquito genome, the scientists designed a pair of TALENS to target a gene whose protein product is essential to the production of eye pigmentation in Aedes aegypti, a mosquito species known for its transmission of the viruses that cause dengue fever.

Using the TALEN pair to edit the gene in the mosquito's germ cells early in development, they were able to change the eye color of a large percentage of the mosquitoes arising in the next generation from black to white.

"To date, efforts to control dengue transmission through genetics have focused entirely on adding material to the mosquito genome. Ensuring that this added material is expressed properly and consistently has been a challenge," Adelman said. "This technology allows us to pursue the same goals, namely, the generation of pathogen-resistant mosquitoes, through subtraction. For example, removing or altering a gene that is critical for pathogen replication."

"Aedes mosquitoes have become increasingly important as vectors of disease from a public health perspective," said George Dimopoulos, a professor of molecular microbiology and immunology at John Hopkins University who was not involved in the study. "The lack of vaccines and drugs for dengue has left the mosquitoes that carry the virus as one of the most promising targets for controlling the disease. A better understanding of how the virus infects the mosquito and other biological properties of the insect will be required to develop intervention strategies that can block virus transmission by the mosquito. The ability to genetically engineer mosquitoes is essential for the study of such biological functions. The TALEN-based system in mosquitoes that that was developed by Dr. Adelman provides this important capacity."

Explore further: Improving the productivity of tropical potato cultivation

Related Stories

Brazil to breed GM mosquitoes to combat dengue

Jul 10, 2012

Brazil said Monday it will breed huge numbers of genetically modified mosquitoes to help stop the spread of dengue fever, an illness that has already struck nearly 500,000 people this year nationwide.

Scientists engineer mosquito immune system to fight malaria

Dec 22, 2011

Researchers at the Johns Hopkins Malaria Research Institute have demonstrated that the Anopheles mosquito's innate immune system could be genetically engineered to block the transmission of malaria-causing parasites to humans. ...

Recommended for you

Building better soybeans for a hot, dry, hungry world

19 hours ago

(Phys.org) —A new study shows that soybean plants can be redesigned to increase crop yields while requiring less water and helping to offset greenhouse gas warming. The study is the first to demonstrate ...

Gene removal could have implications beyond plant science

20 hours ago

(Phys.org) —For thousands of years humans have been tinkering with plant genetics, even when they didn't realize that is what they were doing, in an effort to make stronger, healthier crops that endured climates better, ...

Chrono, the last piece of the circadian clock puzzle?

Apr 15, 2014

All organisms, from mammals to fungi, have daily cycles controlled by a tightly regulated internal clock, called the circadian clock. The whole-body circadian clock, influenced by the exposure to light, dictates the wake-sleep ...

User comments : 0

More news stories

More vets turn to prosthetics to help legless pets

A 9-month-old boxer pup named Duncan barreled down a beach in Oregon, running full tilt on soft sand into YouTube history and showing more than 4 million viewers that he can revel in a good romp despite lacking ...

Revealing camouflaged bacteria

A research team at the Biozentrum of the University of Basel has discovered an protein family that plays a central role in the fight against the bacterial pathogen Salmonella within the cells. The so cal ...

New clinical trial launched for advance lung cancer

Cancer Research UK is partnering with pharmaceutical companies AstraZeneca and Pfizer to create a pioneering clinical trial for patients with advanced lung cancer – marking a new era of research into personalised medicines ...